Interesting q2 presentation

Addressable market US still sitting at 535,000 patients, hope they can grab a fair slab of that. This time pushing the GO machine that gives 7.5% TBSA per cartridge, I notice the shot of 6 machines sitting in the theatre to treat a 50% to 60% surface area case. Why not the machines come free carrying have as many as you want, the cartridges at $6500 each can be all running at once. Also notice the number of EU countries agreements have gone from 3 to now 14. Add Aust and Japan and you have a very sizeable market to grow in. Mini GO gives a TBSA 2.5% a third of GO so guess probably a cartridge will be a half to a third cost.
Thinking my gamble to lash out and up my holding by 12% may work out.